VYLIBRA Trademark

Trademark Overview


On Thursday, March 24, 2016, a trademark application was filed for VYLIBRA with the United States Patent and Trademark Office. The USPTO has given the VYLIBRA trademark a serial number of 86952102. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, January 26, 2024. This trademark is owned by Afaxys, Inc.. The VYLIBRA trademark is filed in the Pharmaceutical Products category with the following description:

Oral contraceptives
vylibra

General Information


Serial Number86952102
Word MarkVYLIBRA
Filing DateThursday, March 24, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, January 26, 2024
Registration Number5498300
Registration DateTuesday, June 19, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2016

Trademark Statements


Goods and ServicesOral contraceptives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 30, 2016
Primary Code005
First Use Anywhere DateMonday, April 9, 2018
First Use In Commerce DateMonday, April 9, 2018

Trademark Owner History


Party NameAfaxys, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCharleston, SC 29403

Party NameAfaxys, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCharleston, SC 29403

Party NameAfaxys, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCharleston, SC 29403

Trademark Events


Event DateEvent Description
Friday, January 26, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, January 26, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 26, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 4, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, June 19, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 24, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 24, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 19, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, May 15, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 14, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 11, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, April 16, 2018USE AMENDMENT FILED
Friday, May 4, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 16, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, April 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 2, 2018SOU EXTENSION 3 GRANTED
Monday, April 2, 2018SOU EXTENSION 3 FILED
Monday, April 2, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, September 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2017SOU EXTENSION 2 GRANTED
Monday, September 25, 2017SOU EXTENSION 2 FILED
Monday, September 25, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 24, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 24, 2017SOU EXTENSION 1 GRANTED
Friday, March 24, 2017SOU EXTENSION 1 FILED
Friday, March 24, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, October 4, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2016ASSIGNED TO EXAMINER
Wednesday, March 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 28, 2016NEW APPLICATION ENTERED

Related Keywords


vylibra contraceptives oral